Skip to content

Study · In vitro (cells) · 2024

3 results

[Gly14]-Humanin ameliorates high glucose-induced endothelial senescence via SIRT6.

Li M, Liu Z, Cao X, Xiao W, Wang S, Zhao C, Zhao Y, Xie Y

Scientific reports28 Dec 2024Cited by 1 (Europe PMC)

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: CC BY-NC-ND. Results still quote short attributed sentences.

Results from this study3

3 results from studies that gave the peptide. No result from this study comes from people.

  1. 01LabIn vitro (cells)Mechanism

    In HUVECs exposed to high glucose, pretreatment with [Gly14]-Humanin antagonized the downregulation of SIRT6.

    In plain wordsIn cells, [Gly14]-Humanin kept SIRT6 from falling under high glucose.

    Peptide
    Humanin
    Outcome
    IncreaseSIRT6 downregulation by high glucose
    Study

    humann: not reported in source

    HUVECs exposed to high glucose
    Comparator
    High glucose without HNG
    Outcome group
    Aging markers · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    pretreatment with [Gly14]-Humanin (HNG) antagonized the downregulation of SIRT6 in response to HG
    1 context sentence
    Summary · context
    Human umbilical vein endothelial cells (HUVECs) were exposed to glucose to induce senescence, determined by β-galactosidase staining and the expressions of p21, p53, and p16.
  2. 02LabIn vitro (cells)Mechanism

    In HUVECs exposed to high glucose, pretreatment with [Gly14]-Humanin alleviated ROS production.

    In plain wordsIn cells, [Gly14]-Humanin reduced production of reactive oxygen species under high glucose.

    Peptide
    Humanin
    Outcome
    DecreaseROS production
    Study

    humann: not reported in source

    HUVECs exposed to high glucose
    Comparator
    High glucose without HNG
    Outcome group
    Aging markers · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    pretreatment with [Gly14]-Humanin (HNG) antagonized the downregulation of SIRT6 in response to HG and alleviated ROS production
    1 context sentence
    Summary · context
    Human umbilical vein endothelial cells (HUVECs) were exposed to glucose to induce senescence, determined by β-galactosidase staining and the expressions of p21, p53, and p16.
  3. 03LabIn vitro (cells)Mechanism

    In HUVECs exposed to high glucose, pretreatment with [Gly14]-Humanin alleviated cell senescence.

    In plain wordsIn cells, [Gly14]-Humanin reduced the signs of aging in blood vessel cells exposed to high glucose.

    Peptide
    Humanin
    Outcome
    DecreaseHigh glucose-induced endothelial senescence
    Study

    humann: not reported in source

    HUVECs exposed to high glucose
    Comparator
    High glucose without HNG
    Outcome group
    Aging markers · Cardiovascular
    Studied dose
    Dose not stated

    Source sentences

    Summary
    pretreatment with [Gly14]-Humanin (HNG) antagonized the downregulation of SIRT6 in response to HG and alleviated ROS production and cell senescence
    1 context sentence
    Summary · context
    Human umbilical vein endothelial cells (HUVECs) were exposed to glucose to induce senescence, determined by β-galactosidase staining and the expressions of p21, p53, and p16.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 21:44 UTC

    Study results updated

  2. Version 1

    13 Oct 2026, 16:31 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.